These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 36352331)

  • 1. The cryptic role of CXCL17/CXCR8 axis in the pathogenesis of cancers: a review of the latest evidence.
    Hashemi SF; Khorramdelazad H
    J Cell Commun Signal; 2023 Sep; 17(3):409-422. PubMed ID: 36352331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role and clinical significance of the CXCL17-CXCR8 (GPR35) axis in breast cancer.
    Guo YJ; Zhou YJ; Yang XL; Shao ZM; Ou ZL
    Biochem Biophys Res Commun; 2017 Nov; 493(3):1159-1167. PubMed ID: 28943434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of CXCL17 and CXCR8 expression in patients with colon cancer.
    Yao H; Lv Y; Bai X; Yu Z; Liu X
    Oncol Lett; 2020 Sep; 20(3):2711-2720. PubMed ID: 32782587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and clinical significance of CXCL17 and GPR35 in endometrial carcinoma.
    Hao J; Gao X; Wang YP; Liu Q; Zhu H; Zhao SJ; Qin QH; Meng J; Li LL; Lin SC; Song Z; Li H
    Anticancer Drugs; 2022 Jun; 33(5):467-477. PubMed ID: 35276691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutting edge: GPR35/CXCR8 is the receptor of the mucosal chemokine CXCL17.
    Maravillas-Montero JL; Burkhardt AM; Hevezi PA; Carnevale CD; Smit MJ; Zlotnik A
    J Immunol; 2015 Jan; 194(1):29-33. PubMed ID: 25411203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comprehensive review of chemokine CXC17 (VCC1) in cancer, infection, and inflammation.
    Gowhari Shabgah A; Jadidi-Niaragh F; Ebrahimzadeh F; Mohammadi H; Askari E; Pahlavani N; Malekahmadi M; Ebrahimi Nik M; Gholizadeh Navashenaq J
    Cell Biol Int; 2022 Oct; 46(10):1557-1570. PubMed ID: 35811438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The protective and pathogenic roles of CXCL17 in human health and disease: Potential in respiratory medicine.
    Choreño-Parra JA; Thirunavukkarasu S; Zúñiga J; Khader SA
    Cytokine Growth Factor Rev; 2020 Jun; 53():53-62. PubMed ID: 32345516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GPR35 mediates lodoxamide-induced migration inhibitory response but not CXCL17-induced migration stimulatory response in THP-1 cells; is GPR35 a receptor for CXCL17?
    Park SJ; Lee SJ; Nam SY; Im DS
    Br J Pharmacol; 2018 Jan; 175(1):154-161. PubMed ID: 29068046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-325-3p mediate the CXCL17/CXCR8 axis to regulate angiogenesis in hepatocellular carcinoma.
    Li L; Ji Y; Chen YC; Zhen ZJ
    Cytokine; 2021 May; 141():155436. PubMed ID: 33515898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The therapeutic potential of orphan GPCRs, GPR35 and GPR55.
    Shore DM; Reggio PH
    Front Pharmacol; 2015; 6():69. PubMed ID: 25926795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of CXCL17 and GPR35 in Gastric Cancer Initiation and Progression.
    Li Y; Liu A; Liu S; Yan L; Yuan Y; Xu Q
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36614059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What defines a chemokine? - The curious case of CXCL17.
    Giblin SP; Pease JE
    Cytokine; 2023 Aug; 168():156224. PubMed ID: 37210967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CXCL17 is a mucosal chemokine elevated in idiopathic pulmonary fibrosis that exhibits broad antimicrobial activity.
    Burkhardt AM; Tai KP; Flores-Guiterrez JP; Vilches-Cisneros N; Kamdar K; Barbosa-Quintana O; Valle-Rios R; Hevezi PA; Zuñiga J; Selman M; Ouellette AJ; Zlotnik A
    J Immunol; 2012 Jun; 188(12):6399-406. PubMed ID: 22611239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for the Existence of a CXCL17 Receptor Distinct from GPR35.
    Binti Mohd Amir NAS; Mackenzie AE; Jenkins L; Boustani K; Hillier MC; Tsuchiya T; Milligan G; Pease JE
    J Immunol; 2018 Jul; 201(2):714-724. PubMed ID: 29875152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CXCL17 Attenuates Imiquimod-Induced Psoriasis-like Skin Inflammation by Recruiting Myeloid-Derived Suppressor Cells and Regulatory T Cells.
    Oka T; Sugaya M; Takahashi N; Takahashi T; Shibata S; Miyagaki T; Asano Y; Sato S
    J Immunol; 2017 May; 198(10):3897-3908. PubMed ID: 28389593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased epithelial and sputum miR-221-3p associates with airway eosinophilic inflammation and CXCL17 expression in asthma.
    Zhang K; Liang Y; Feng Y; Wu W; Zhang H; He J; Hu Q; Zhao J; Xu Y; Liu Z; Zhen G
    Am J Physiol Lung Cell Mol Physiol; 2018 Aug; 315(2):L253-L264. PubMed ID: 29644894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CXCL17 Attenuates Diesel Exhaust Emissions Exposure-Induced Lung Damage by Regulating Macrophage Function.
    Yin Y; Mu C; Wang J; Wang Y; Hu W; Zhu W; Yu X; Hao W; Zheng Y; Li Q; Han W
    Toxics; 2023 Jul; 11(8):. PubMed ID: 37624152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of the IL-17 signalling pathway by the CXCL17-GPR35 axis affects drug resistance and colorectal cancer tumorigenesis.
    Bu J; Yan W; Huang Y; Lin K
    Am J Cancer Res; 2023; 13(5):2172-2187. PubMed ID: 37293165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucosal Chemokines.
    Hernández-Ruiz M; Zlotnik A
    J Interferon Cytokine Res; 2017 Feb; 37(2):62-70. PubMed ID: 28207301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CXCL17-derived CD11b
    Hsu YL; Yen MC; Chang WA; Tsai PH; Pan YC; Liao SH; Kuo PL
    Breast Cancer Res; 2019 Feb; 21(1):23. PubMed ID: 30755260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.